These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14185784)

  • 1. [THE USE OF RIFAMYCIN SV IN ENDOBRONCHIAL ADMINISTRATION FOR TUBERCULOUS PROCESSES].
    D ALFONSO G
    Chemotherapia (Basel); 1963; 12():553-4. PubMed ID: 14185784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifamycin SV in treatment by endobronchial route of pulmonary tuberculosis].
    MARCATILI S; NATALE P
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():244-7. PubMed ID: 13932775
    [No Abstract]   [Full Text] [Related]  

  • 3. [LOCAL USE OF "RIFAMYCIN-SV"(RF-SV) IN PULMONARY TUBERCULOSIS].
    CUCCHIANIACEVEDO R; LERNER S; FIORINO AR; IRURZUN A
    Rev Esp Tuberc; 1964 May; 33():229-33. PubMed ID: 14169314
    [No Abstract]   [Full Text] [Related]  

  • 4. [RIFAMYCIN SV IN THE LOCAL THERAPY OF TUBERCULOUS CAVERNS IN TREATMENT WITH INTRACAVITARY ASPIRATION].
    BLASI A
    Chemotherapia (Basel); 1963; 12():542-8. PubMed ID: 14185781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical contribution to the treatment of pulmonary tuberculosis with rifamycin SV].
    SISTI MA
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():308-10. PubMed ID: 13977765
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE USE OF RIFAMYCIN SV IN COMBINATION WITH OPERATIVE INTERVENTIONS IN PULMONARY TUBERCULOSIS].
    DIMEZZA F
    Chemotherapia (Basel); 1963; 12():551-2. PubMed ID: 14185783
    [No Abstract]   [Full Text] [Related]  

  • 7. [CONTRIBUTION TO THE STUDY OF THE GENERAL AND LOCAL THERAPY OF PULMONARY AND PLEURAL TUBERCULOSIS WITH RIFAMYCIN SV (RIFOCINE)].
    BARBA G
    J Med (Oporto); 1965 Mar; 56():521-8. PubMed ID: 14326689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rifamycin SV in endocavitary aspiration].
    LENCI E; FAENZI G
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():311-6. PubMed ID: 13929594
    [No Abstract]   [Full Text] [Related]  

  • 9. [RIFAMYCIN SV IN THE THERAPY OF HUMAN PULMONARY TUBERCULOSIS].
    GRASSI C; BASILICO F
    Chemotherapia (Basel); 1963; 12():526-32. PubMed ID: 14185779
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE USE OF RIFAMYCIN SV IN SUBJECTS HOSPITALIZED FOR THE FIRST TIME].
    CATENA E
    Chemotherapia (Basel); 1963; 12():549-50. PubMed ID: 14185782
    [No Abstract]   [Full Text] [Related]  

  • 11. [LOCAL USE OF RIFOMYCIN-SV (RF-SV) IN PULMONARY TUBERCULOSIS. PRELIMINARY COMMUNICATION].
    CUCCHIANIACEVEDO R; LERNER S; FIORINO AR; IRURZUN A
    Arch Argent Tisiol Neumonol; 1963; 39():159-63. PubMed ID: 14126676
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical observations of the use of rifamycin SV in tuberculous processes].
    MAZZINI C; GIACHI R
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():334-5. PubMed ID: 13934258
    [No Abstract]   [Full Text] [Related]  

  • 13. [1st clinical observations in the tuberculosis field with rifamycin SV administered by venous perfusion].
    LUCCHESI M; BANCALE A; PALLOTTA G; TERMINE A
    Ann Ist Carlo Forlanini; 1962; 22():441-69. PubMed ID: 13931419
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modifications of the bacteriologic findings in tuberculotics subjected to treatment with rifamycin SV].
    NITTI V; VIRGILIO R; NINNI A
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():269-80. PubMed ID: 13938849
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE USES OF RIFAMYCIN SV IN THE CLINICA TISIOLOGICA DI NAPOLI].
    RESCIGNO B
    Chemotherapia (Basel); 1963; 12():501-5. PubMed ID: 14185776
    [No Abstract]   [Full Text] [Related]  

  • 16. [Local application of rifamycin SV in caverns treated by endocavitary aspiration].
    SISTI F; VACCARO L
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():251-6. PubMed ID: 13977764
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE ROUTES AND METHODS OF ADMINISTRATION OF RIFAMYCIN SV. THE TOLERANCE OF THE BODY].
    NITTI V
    Chemotherapia (Basel); 1963; 12():482-91. PubMed ID: 14185774
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE USE OF RIFAMYCIN SV REDUCES THE PERIOD OF INTRACAVITARY ASPIRATION].
    SISTI F
    Chemotherapia (Basel); 1963; 12():561-2. PubMed ID: 14185788
    [No Abstract]   [Full Text] [Related]  

  • 19. [ACTIVITY OF RIFAMYCIN SV IN THE TREATMENT OF TUBERCULOSIS].
    TACQUET A
    Chemotherapia (Basel); 1963; 12():492-500. PubMed ID: 14185775
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE USE OF RIFAMYCIN SV MAKES THE RESULTS OF INTRACAVITARY ASPIRATION MORE RAPID AND RELIABLE].
    VACCARO L
    Chemotherapia (Basel); 1963; 12():563-4. PubMed ID: 14185789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.